1339891-76-7

Basic information

• Product Name: methyl 5-chloroimidazo[1,2-c]pyrimidine-7-carboxylate
• CAS NO: 1339891-76-7
• Molecular Weight: 211.608
• Mol File: 1339891-76-7.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: methyl 5-chloroimidazo[1,2-c]pyrimidine-7-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 5-chloroimidazo[1,2-c]pyrimidine-7-carboxylate(1339891-76-7)
• EPA Substance Registry System: methyl 5-chloroimidazo[1,2-c]pyrimidine-7-carboxylate(1339891-76-7)

Safety Data

• Hazardous Substances Data: 1339891-76-7(Hazardous Substances Data)

Upstream product

• 6299-85-0 2,6-dichloropyrimidine-4-carboxylic acid methyl ester 
• 56817-09-5 7-chloro-5H,6H-imidazo[1,2-c]pyrimidin-5-one 
• 1339891-11-0 7-chloro-5-(methylsulfanyl)imidazo[1,2-c]pyrimidine hydrochloride 
• 1339891-74-5 methyl 5-hydroxyimidazo[1,2-c]pyrimidine-7-carboxylate 
• 7252-83-7 1-bromo-2,2-dimethoxyethane 
• 944129-00-4 methyl 6-amino-2-chloropyrimidine-4-carboxylate 

Relevant articles and documents

ALKYNYL ALCOHOLS AND METHODS OF USE

The invention relates to compounds of Formula (0): wherein A1-A8, R4 and R5 each has the meaning as described herein. Compounds of Formula (0) and pharmaceutical compositions thereof are useful in the treatment of diseases and disorders in which undesired or over-activation of NF-kB signaling is observed.

5, 7-SUBSTITUTED-IMIDAZO [1, 2-C] PYRIMIDINES AS INHIBITORS OF JAK KINASES

Compounds of Formula I: (Formula should be inserted here) and stereoisomers and pharmaceutically acceptable salts and solvates thereof in which R1, R2, R3, R4, R5, R6, R7, X1 and X2 have the meanings given in the specification, are inhibitors of one or more JAK kinases and are useful in the treatment of autoimmune diseases, inflammatory diseases, rejection of transplanted organs, tissues and cells, as well as hematologic disorders and malignancies and their co-morbidities.